Dear Colleagues,

Remote patient monitoring is an element of telehealth. It involves the collection, transmission, and evaluation of relevant patient data using electronic devices, as well as decision making regarding appropriate clinical management. Cardiac implantable electronic devices (CIED) have extensive remote monitoring capabilities based on validated sensors that enable the collection of data on the device performance, arrhythmic profile, patient physical activity, and a series of parameters related to pathophysiological changes, including the detection of impending or worsening heart failure. To improve the management of patients with heart failure, several patient-specific parameters can be remotely monitored through CIEDs and combined to derive multiparametric scores for the prediction of a patient’s risk of worsening heart failure, with a good sensitivity and moderate specificity.

Pre-clinical alerts are remotely transmitted by CIEDs to physicians, thus enabling early patient management with the potential to prevent hospitalizations due to heart failure. However, this requires an appropriate form of organization, involving close coordination between physicians in charge of patient care, nurses, technicians, patients, and caregivers.

This Special Issue aims to provide an overview of the progress achieved in recent years regarding the technology of remote monitoring through CIEDs, as well as progress in the organization of remote care. It aims to define questions that are still open regarding the clinical management of alerts, coordination between caregivers, and coverage and reimbursement from the perspective of the implementation of remote patient monitoring as a standard of care for patients using CIEDs.

Prof. Dr. Giuseppe Boriani
Dr. Massimiliano Maines
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• remote monitoring
• cardiac pacing
• device therapy
• arrhythmias
• heart failure
• integrated care
• decision making
• guidelines
• digital health
• telemedicine